Evaluation of: Waldmann TA, Conlon KC, Stewart DM et al. Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-β-1 mAb in patients with T-cell large granular lymphocytic leukemia.

Merck halted 2 phase 3 KEYNOTE trials of pembrolizumab, and the MonumenTAL-1 trial data is discussed. Researcher Mayra Shanley, MD, and team set out to evaluate the efficacy of natural killer (NK) ...

Cytokine gene vaccine therapy involving IL-15 or IL-2 has also been shown in brain tumor animal models to stimulate a potent antitumor immune response and prolong survival. In this Research Topic, we ...

The large land surrounding the US-20 and IL-2 interchange could be used for industrial development very soon. Monday night, ...

Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.

Whether commercially available semi-automatic rifles now banned in Illinois are common or too similar to military grade ...

Approval of the dual-acting interleukin (IL)-23 inhibitor in ulcerative colitis was based on findings from QUASAR, an ongoing ...

Kjerstad, 25, the No. 2 overall pick of the Orioles in the 2020 draft, was in Sunday's starting lineup batting fourth as the designated hitter. He entered Sunday hitting .261 with three home runs ...

The Kansas City Royals placed right-hander Chris Stratton on the 15-day injured list Saturday with a right forearm flexor strain and recalled left-hander Angel Zerpa from Triple-A Omaha.

The Los Angeles Dodgers may have dodged losing another player to the injured. Outfielder Teoscar Hernández exited Friday's loss to the Cleveland Guardians (CLE 3, LAD 1) after taking a Matthew ...